Cell Therapy

The transition of a revolutionary medical concept from the isolation of a laboratory bench to the bedside of a critically ill patient represents one of the most significant challenges in modern oncology. The Ludwig Institute for Cancer Research recently entered a transformative phase by appointing

While CAR-T cell therapy has revolutionized the treatment of liquid cancers, the dense and deceptive landscape of solid tumors like glioblastoma has long remained an impenetrable fortress—until now. Glioblastoma is recognized as one of the most aggressive malignancies in existence, with a five-year

In the high-stakes world of biopharmaceutical research, few names carry as much weight as Ivan Kairatov. As a seasoned expert in the field, Kairatov has spent decades navigating the complex intersection of biological innovation and therapeutic development, bridging the gap between fundamental

The traditional view of acute myeloid leukemia as a localized disease of the bone marrow is undergoing a radical transformation as researchers uncover the sophisticated ways this cancer colonizes distant organs like the lungs. While clinical experts have long recognized that respiratory failure is

Ivan Kairatov is a leading figure in biopharmaceutical innovation, bringing years of dedicated research and development experience to the intersection of oncology and the human microbiome. As an expert who has watched the landscape of cancer treatment shift from traditional chemotherapy to the

The long-standing ambition of regenerating damaged myocardial tissue has frequently encountered a formidable barrier that separates laboratory success from widespread clinical application. While the biological potential of stem cells to transform into functional heart muscle is well-documented, the